Zkusit zdarma
Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc.

STOK
Cena:
$ 29.34
-0.33 (-1.11%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

12:27 21-05-2026

STOK rides high as zorevunersen advances in late-stage Dravet syndrome studies and heads toward FDA ...

Stoke Therapeutics Q1 Earnings Call Highlights

Stoke Therapeutics Q1 Earnings Call Highlights

0:09 09-05-2026

Stoke Therapeutics NASDAQ: STOK said its lead investigational therapy zorevunersen continued to show...

Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call Transcript

Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call Transcript

2:21 08-05-2026

Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call Transcript...

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

20:12 07-05-2026

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.79 per share versus the Zacks C...

Stoke Therapeutics: Zorevunersen Has Disease-Modifying Potential In Dravet Syndrome

Stoke Therapeutics: Zorevunersen Has Disease-Modifying Potential In Dravet Syndrome

16:39 01-05-2026

I initiate Stoke Therapeutics with a Buy rating, driven by late-stage progress for zorevunersen in S...

Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

16:01 08-04-2026

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company ...

Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors

Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors

16:01 07-04-2026

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company ...

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

20:32 27-03-2026

The chair of Stoke Therapeutics disclosed selling 4,355 shares for roughly $174,000 at around $40.00...

Assenagon Asset Management S.A. Boosts Position in Stoke Therapeutics, Inc. $STOK

Assenagon Asset Management S.A. Boosts Position in Stoke Therapeutics, Inc. $STOK

3:07 26-03-2026

Assenagon Asset Management S.A. boosted its holdings in Stoke Therapeutics, Inc. (NASDAQ: STOK) by 3...

Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally

Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally

12:35 24-03-2026

The chief medical officer of Stoke Therapeutics disposed of 14,311 Common Stock shares for a transac...

Stoke Therapeutics (NASDAQ:STOK) Trading Down 6.6% After Insider Selling

Stoke Therapeutics (NASDAQ:STOK) Trading Down 6.6% After Insider Selling

1:30 14-03-2026

Stoke Therapeutics, Inc. (NASDAQ: STOK - Get Free Report)'s share price was down 6.6% during mid-day...

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome

17:06 04-03-2026

BEDFORD, Mass. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biote...

45,205 Shares in Stoke Therapeutics, Inc. $STOK Acquired by Principal Financial Group Inc.

45,205 Shares in Stoke Therapeutics, Inc. $STOK Acquired by Principal Financial Group Inc.

3:32 19-02-2026

Principal Financial Group Inc. bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ: ...

Penserra Capital Management LLC Acquires New Position in Stoke Therapeutics, Inc. $STOK

Penserra Capital Management LLC Acquires New Position in Stoke Therapeutics, Inc. $STOK

4:49 06-02-2026

Penserra Capital Management LLC bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:...

Stoke Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Stoke Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

16:01 04-02-2026

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company ...

Campbell & CO Investment Adviser LLC Acquires Shares of 30,418 Stoke Therapeutics, Inc. $STOK

Campbell & CO Investment Adviser LLC Acquires Shares of 30,418 Stoke Therapeutics, Inc. $STOK

4:55 21-01-2026

Campbell and CO Investment Adviser LLC bought a new position in Stoke Therapeutics, Inc. (NASDAQ: ST...

Stoke Therapeutics: FDA Delay Doesn't Change Zorevunersen's Opportunity

Stoke Therapeutics: FDA Delay Doesn't Change Zorevunersen's Opportunity

8:49 15-01-2026

Stoke Therapeutics' TANGO ASO platform can upregulate the functional allele, targeting haploinsuffic...

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

14:00 11-01-2026

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company ...

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of “Buy” by Analysts

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of “Buy” by Analysts

1:32 22-12-2025

Stoke Therapeutics, Inc. (NASDAQ: STOK - Get Free Report) has earned a consensus rating of "Buy" fro...

Assenagon Asset Management S.A. Has $21.16 Million Position in Stoke Therapeutics, Inc. $STOK

Assenagon Asset Management S.A. Has $21.16 Million Position in Stoke Therapeutics, Inc. $STOK

3:27 20-12-2025

Assenagon Asset Management S.A. raised its holdings in Stoke Therapeutics, Inc. (NASDAQ: STOK) by 67...

close

STOKE THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 STUDY OF STK-002, A POTENTIAL DISEASE-MODIFYING MEDICINE FOR THE TREATMENT OF AUTOSOMAL DOMINANT OPTIC ATROPHY (ADOA)

11-02-2026
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTECHNOLOGY COMPANY DE...
Více zde

STOKE THERAPEUTICS TO PRESENT AT THE GUGGENHEIM EMERGING OUTLOOK: BIOTECH SUMMIT 2026

04-02-2026
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

ANCHOR LINE PARTNERS SUPPORTS STOKE THERAPEUTICS' GROWTH BY SECURING A 98,500 SQUARE-FOOT LEASE IN WALTHAM, MA

27-01-2026
NEW HEADQUARTERS WILL SUPPORT COMPANY'S WORK TO DELIVER ZOREVUNERSEN, A POTENTIAL DISEASE-MODIFYING ...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-01-2026
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS ANNOUNCES UPDATES TO TIMELINES FOR THE COMPLETION OF ENROLLMENT AND A PHASE 3 DATA READOUT FROM THE EMPEROR STUDY OF ZOREVUNERSEN FOR THE TREATMENT OF DRAVET SYNDROME

11-01-2026
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2026
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-12-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

BIOGEN AND STOKE THERAPEUTICS PRESENT DATA THAT FURTHER SUPPORT THE DISEASE-MODIFYING POTENTIAL OF ZOREVUNERSEN, AN INVESTIGATIONAL MEDICINE FOR THE TREATMENT OF DRAVET SYNDROME, AT THE 2025 AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING

05-12-2025
—LONG-TERM PHASE 1/2A AND OPEN LABEL EXTENSION (OLE) DATA FOR ZOREVUNERSEN ON TOP OF STANDARD OF C...
Více zde

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE PRESENTATIONS AT THE 2025 AMERICAN EPILEPSY SOCIETY ANNUAL MEETING

01-12-2025
BEDFORD, MASS. & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTE...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

18-11-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE PUBLICATION OF TWO-YEAR NATURAL HISTORY DATA DEMONSTRATING THE SEVERITY OF DRAVET SYNDROME, INCLUDING FREQUENT SEIZURES AND SIGNIFICANT COGNITIVE AND BEHAVIORAL IMPAIRMENTS

17-11-2025
BEDFORD, MASS., & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOT...
Více zde

STOKE THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

04-11-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS TO HOST WEBCAST AND CONFERENCE CALL TO DISCUSS THIRD QUARTER 2025 BUSINESS AND FINANCIAL UPDATES

30-10-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS PRESENTS TWO-YEAR NATURAL HISTORY DATA FROM PATIENTS WITH AUTOSOMAL DOMINANT OPTIC ATROPHY (ADOA)

20-10-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTECHNOLOGY COMPANY DE...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-10-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS AND BIOGEN PRESENT NEW DATA AT THE 54TH CHILD NEUROLOGY SOCIETY (CNS) ANNUAL MEETING THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME

09-10-2025
BEDFORD, MASS., & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOT...
Více zde

STOKE THERAPEUTICS APPOINTS IAN F. SMITH AS CHIEF EXECUTIVE OFFICER

06-10-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTECHNOLOGY COMPANY DE...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-09-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS AND BIOGEN PRESENT DATA AT THE 36TH INTERNATIONAL EPILEPSY CONGRESS THAT SUPPORT THE POTENTIAL FOR ZOREVUNERSEN TO BE THE FIRST DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME

02-09-2025
BEDFORD, MASS. & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTE...
Více zde

STOKE THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN SEPTEMBER 2025

28-08-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE PRESENTATIONS OF CLINICAL DATA FROM STUDIES OF ZOREVUNERSEN FOR THE POTENTIAL TREATMENT OF DRAVET SYNDROME AT THE 36TH INTERNATIONAL EPILEPSY CONGRESS

25-08-2025
BEDFORD, MASS. & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTE...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

18-08-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF STOKE THERAPEUTICS, INC. (NASDAQ: STOK)

18-08-2025
NEW YORK , AUG. 18, 2025 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING ...
Více zde

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE FIRST PATIENT DOSED IN PHASE 3 EMPEROR STUDY OF ZOREVUNERSEN, A POTENTIAL DISEASE-MODIFYING TREATMENT FOR DRAVET SYNDROME

11-08-2025
BEDFORD, MASS., & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOT...
Více zde

STOKE THERAPEUTICS TO HOST WEBCAST AND CONFERENCE CALL TO DISCUSS SECOND QUARTER 2025 BUSINESS AND FINANCIAL UPDATES

07-08-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS TO PRESENT AT THE CANACCORD GENUITY 45TH ANNUAL GROWTH CONFERENCE

06-08-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-07-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE PRESENTATION OF DATA FROM STUDIES OF ZOREVUNERSEN, AN INVESTIGATIONAL MEDICINE FOR DRAVET SYNDROME, AT THE 16TH EUROPEAN PAEDIATRIC NEUROLOGY SOCIETY (EPNS) CONGRESS

10-07-2025
BEDFORD, MASS., & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOT...
Více zde

STOKE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

17-06-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

STOKE THERAPEUTICS TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

29-05-2025
BEDFORD, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK) IS A BIOTECHNOLOGY COMPANY ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-26 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-05 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-10-06 01:00:008-KStáhnout
2025-10-06 00:00:008-KStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 00:00:008-KStáhnout
2025-07-10 01:00:008-KStáhnout
2025-07-10 00:00:008-KStáhnout
2025-06-04 01:00:008-KStáhnout
2025-06-04 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-18 00:00:008-KStáhnout
2025-03-18 00:00:0010-KStáhnout
2025-03-17 23:00:008-KStáhnout
2025-03-17 23:00:0010-KStáhnout
2025-02-18 00:00:008-KStáhnout
2025-02-17 23:00:008-KStáhnout
2025-01-07 00:00:008-KStáhnout
2025-01-06 23:00:008-KStáhnout
2024-12-06 00:00:008-KStáhnout
2024-12-05 23:00:008-KStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-05 00:00:0010-QStáhnout
2024-11-04 23:00:008-KStáhnout
2024-11-04 23:00:0010-QStáhnout
2024-09-10 01:00:008-KStáhnout
2024-09-10 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-06-21 01:00:008-KStáhnout
2024-06-21 00:00:008-KStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 01:00:0010-QStáhnout
2024-05-06 00:00:008-KStáhnout
2024-05-06 00:00:0010-QStáhnout
2024-04-29 01:00:008-KStáhnout
2024-04-29 00:00:008-KStáhnout
2024-03-28 00:00:008-KStáhnout
2024-03-27 23:00:008-KStáhnout
2024-03-25 00:00:008-KStáhnout
2024-03-25 00:00:0010-KStáhnout
2024-03-24 23:00:008-KStáhnout
2024-03-24 23:00:0010-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-14 00:00:008-KStáhnout
2023-12-13 23:00:008-KStáhnout
2023-12-01 00:00:008-KStáhnout
2023-11-30 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-10-26 01:00:008-KStáhnout
2023-10-26 00:00:008-KStáhnout
2023-09-20 01:00:008-KStáhnout
2023-09-20 00:00:008-KStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:008-KStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-07-25 01:00:008-KStáhnout
2023-07-25 00:00:008-KStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-03-15 00:00:008-KStáhnout
2023-03-14 23:00:008-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-06 00:00:0010-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-03-05 23:00:0010-KStáhnout
2023-02-03 00:00:008-KStáhnout
2023-02-02 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-02 00:00:008-KStáhnout
2022-12-01 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-06-08 01:00:008-KStáhnout
2022-06-08 00:00:008-KStáhnout
2022-05-20 01:00:008-KStáhnout
2022-05-20 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-03-10 00:00:008-KStáhnout
2022-03-10 00:00:0010-KStáhnout
2022-03-09 23:00:008-KStáhnout
2022-03-09 23:00:0010-KStáhnout
2022-02-17 00:00:008-KStáhnout
2022-02-16 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-12-03 00:00:008-KStáhnout
2021-12-02 23:00:008-KStáhnout
2021-11-08 00:00:008-KStáhnout
2021-11-08 00:00:0010-QStáhnout
2021-11-07 23:00:008-KStáhnout
2021-11-07 23:00:0010-QStáhnout
2021-09-21 01:00:008-KStáhnout
2021-09-21 00:00:008-KStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
2021-06-09 01:00:008-KStáhnout
2021-06-09 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-03-09 00:00:008-KStáhnout
2021-03-09 00:00:0010-KStáhnout
2021-03-08 23:00:008-KStáhnout
2021-03-08 23:00:0010-KStáhnout
2021-02-05 00:00:008-KStáhnout
2021-02-04 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-20 00:00:008-KStáhnout
2020-11-19 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-10-07 01:00:008-KStáhnout
2020-10-07 00:00:008-KStáhnout
2020-08-21 01:00:008-KStáhnout
2020-08-21 00:00:008-KStáhnout
2020-08-17 01:00:008-KStáhnout
2020-08-17 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-07-09 01:00:008-KStáhnout
2020-07-09 00:00:008-KStáhnout
2020-06-04 01:00:008-KStáhnout
2020-06-04 00:00:008-KStáhnout
2020-05-15 01:00:008-KStáhnout
2020-05-15 01:00:0010-QStáhnout
2020-05-15 00:00:008-KStáhnout
2020-05-15 00:00:0010-QStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-04-15 01:00:008-KStáhnout
2020-04-15 00:00:008-KStáhnout
2020-03-23 00:00:008-KStáhnout
2020-03-23 00:00:0010-KStáhnout
2020-03-22 23:00:008-KStáhnout
2020-03-22 23:00:0010-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-12-09 00:00:008-KStáhnout
2019-12-08 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-08-14 01:00:008-KStáhnout
2019-08-14 01:00:0010-QStáhnout
2019-08-14 00:00:008-KStáhnout
2019-08-14 00:00:0010-QStáhnout
preloader